Physician

Ariel O Antezana

According to 2025 Medicare claims, Ariel Antezana (NPI: 1962737080) practices neurology in the Alexandria, LA market, with the plurality of this provider's patient population coming from Rapides, LA. This provider's primary affiliated billing organization is NEUROMEDICAL CLINIC OF CENLA,L.L.C. (NPI: 1760643670; TIN: 262357997) and primary practice location at 71301-3900. Antezana is affiliated with the CHRISTUS Health Quality Care Alliance (ACO ID: A3029), participating under the MSSP model.

Antezana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 903 traditional Medicare patients, billed 9,602 HCPCS/CPT codes, and received $350,035 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 2,311 prescription claims across 449 beneficiaries totaling $3,043,135 in drug costs, led by Ocrevus (Ocrelizumab). 2019 DME data shows 56 claims. Open Payments data shows 312 records totaling $444,012. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $108,460 and ending at $350,035. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $343,150 to $3,043,135. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,079 to $11,476.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$256K$512K2015 Medicare payment: $108,460 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $152,385 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $340,279 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $511,921 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $474,383 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $211,863 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $300,015 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $304,892 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $290,847 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $350,035 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153942,326$108,460
20166133,156$152,385
20176847,803$340,279
201868010,544$511,921
201969910,899$474,383
20206796,347$211,863
20217977,311$300,015
20228576,135$304,892
20238575,026$290,847
20249039,602$350,035

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.4M$4.8M2015 Drug cost: $343,150 (USD; Tot_Drug_Cst)2016 Drug cost: $725,189 (USD; Tot_Drug_Cst)2017 Drug cost: $797,047 (USD; Tot_Drug_Cst)2018 Drug cost: $1,824,645 (USD; Tot_Drug_Cst)2019 Drug cost: $2,696,754 (USD; Tot_Drug_Cst)2020 Drug cost: $4,818,721 (USD; Tot_Drug_Cst)2021 Drug cost: $4,455,011 (USD; Tot_Drug_Cst)2022 Drug cost: $4,083,128 (USD; Tot_Drug_Cst)2023 Drug cost: $3,233,607 (USD; Tot_Drug_Cst)2024 Drug cost: $3,043,135 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015169806$343,150
20162511,602$725,189
20173272,331$797,047
20183332,419$1,824,645
20193762,620$2,696,754
20204133,070$4,818,721
20214412,821$4,455,011
20224352,563$4,083,128
20233962,320$3,233,607
20244492,311$3,043,135

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$818$1.6K2018 Medicare payment: $891 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,635 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R37$891
2019N/R56$1,635
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95816Measurement of brain wave activity (eeg), awake and drowsy309316$222
93886Complete ultrasound of within the brain blood flow189189$183
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more188188$110
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more412562$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more330496$57

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OcrevusOcrelizumab173,048$671,345
Gamunex-CImmune Globul G/Gly/Iga Avg 46531,113$248,877
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5032826$181,430
Kesimpta PenOfatumumab15436$149,756
OctagamImmun Globg(Igg)/Malt/Iga Ov5021441$138,282

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.289$25,632E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.23$418,379Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ariel O. Antezana?

Tedicare shows public-source Medicare data for Ariel O. Antezana (NPI 1962737080), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ariel O. Antezana have ACO affiliation data?

Ariel O. Antezana is shown with ACO affiliation data for CHRISTUS Health Quality Care Alliance (MSSP, ACO ID A3029).

What billing organization is linked to Ariel O. Antezana?

Ariel O. Antezana is linked to NEUROMEDICAL CLINIC OF CENLA,L.L.C. (billing NPI 1760643670) in the available physician profile data.

Does Ariel O. Antezana have Open Payments data?

Ariel O. Antezana has 312 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.